Bellevue Life Sciences Acquisition Corp. (BLAC)

Market Cap	60.11M
Revenue (ttm)	n/a
Net Income (ttm)	75,043
Shares Out	5.62M
EPS (ttm)	0.01
PE Ratio	1,068.50
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Open	10.69
Previous Close	10.69
Day's Range	10.69 - 10.69
52-Week Range	10.11 - 11.16
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About BLAC

Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

• Industry: Shell Companies
• Sector: Financials
• IPO Date: Feb 10, 2023
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: BLAC